image description

Tag: GSK

Update from LRA’s President on COVID-19 Vaccines in Lupus

January 14, 2020 Dear Friends, Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank you so much for your kindness and generosity in 2020 and prior years. 2021 starts off with some exciting milestones for the lupus community including a new treatment for lupus nephritis. But  Recently, our […] Read More

LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis

September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s New England Journal of Medicine, demonstrating that GSK’s drug Benlysta® (belimumab) significantly improved kidney function in adults with lupus nephritis, the most common severe complication of lupus causing inflammation and serious damage to the kidney. The […] Read More

Join ManyOne Can. Walk with Us to Cure Lupus Sept. 12!

July 2, 2020   Saturday, September 12th, 2020 12:00 – 2:00 PM, EDT Register Now ►   The Lupus Research Alliance is excited to announce the reimagination of our ManyOne Can. Walk with Us to Cure Lupus presented by GSK. This celebratory Walk experience will unite the entire lupus community as never before – behind one goal, on […] Read More

Promising News from Major Medical Meeting, EULAR

Updated June 5, 2020 One of the largest meetings for rheumatologists went virtual this year to enable scientists from around the world to share their latest findings amid the COVID-19 pandemic. EULAR, the e-Congress of the European League Against Rheumatism, runs June 3 -6, and LRA is pleased to share promising results from clinical trials […] Read More